Latest / Stock Movers / Novo Rebounds, Greggs Drops, UniCredit Pays Out
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio news, The.
- 0:08Speaker 2: Stock Movers Report, your roundup of companies making moves in
- 0:12Speaker 2: the stock market, harnessing the power of Bloomberg Data.
- 0:16Speaker 3: Well, let's take a look at some stocks on the
- 0:18Speaker 3: move today in Europe. I'm Stephen Carroll and I'm joined
- 0:20Speaker 3: by Boomberg's Breaking news editor Louise Moon.
- 0:22Speaker 4: Luise, good morning.
- 0:24Speaker 3: Let's start with Novo Nordisk, which appears to be happy
- 0:28Speaker 3: about dodging some imitation.
- 0:31Speaker 1: Indeed, yes, shares are surging for Nova, and notice this morning,
- 0:35Speaker 1: reversing what was a plunge essentially last week.
- 0:39Speaker 4: And this is all on the back of the same story.
- 0:40Speaker 1: So another company, him and hers, pulled a copycat version
- 0:45Speaker 1: of Novo's we goo vi weight loss pill. They pulled
- 0:48Speaker 1: that over the weekend. They said they're going to stop
- 0:51Speaker 1: offering that treatment. And that's after the US FDA pledged
- 0:55Speaker 1: to crack down on copycats.
- 0:57Speaker 4: So this is all on the back of new used last.
- 1:00Speaker 1: Week that him and hers were going to offer this
- 1:04Speaker 1: cheaper knockoff of Novo, and at the time that really
- 1:08Speaker 1: hit Novo's shares. Essentially, it's really essential that this pill
- 1:15Speaker 1: is really essential for Novo's recovery. It's kind of pinning
- 1:17Speaker 1: its comeback on the pill. You know, Novo has been
- 1:21Speaker 1: suffering for a host of reasons, partly on a lot
- 1:25Speaker 1: of competition, particularly from Eli Lilly that's put a lot
- 1:28Speaker 1: of pressure on the company. There's also been pressure from
- 1:31Speaker 1: the Trump administration, and so they're grappling with these issues
- 1:35Speaker 1: and they're really pinning their hopes on a comeback on
- 1:37Speaker 1: this pill. And then news of this copycat hitten Novo
- 1:41Speaker 1: shares last week. So the news now that this is
- 1:45Speaker 1: going to be pulled is really benefitting them this morning,
- 1:47Speaker 1: and we're seeing shares rise on the back of that.
- 1:49Speaker 3: Yeah, and just in the US, Hymns and Hers shares
- 1:52Speaker 3: in pre market down fourteen and a half percent on
- 1:54Speaker 3: that story as well. And there is a connection, Louise
- 1:57Speaker 3: to the story we're going to next, and that's around Greg's.
- 2:00Speaker 3: Their shares are dan tell us more.
- 2:01Speaker 1: Yes in a similar space a similar light. So you
- 2:05Speaker 1: say shares down touched a two month flow. That's for
- 2:07Speaker 1: Greg's in the UK. This is after Jeffries downgraded Greg's
- 2:10Speaker 1: to a hold and they cut their price target by
- 2:13Speaker 1: more than a third, and they're saying that the uptake
- 2:16Speaker 1: of weight loss drugs like that we've been speaking about
- 2:18Speaker 1: with Novo is a headwind to Greg's earnings outlooks. So
- 2:22Speaker 1: the analyst is saying that this rapid uptake of these
- 2:25Speaker 1: weight loss drugs has become what it calls a structural headwind.
- 2:28Speaker 1: So it's assuming now that there'll be lower lighte like sales,
- 2:30Speaker 1: more limited profit growth for Greg's on the back of that. Essentially,
- 2:34Speaker 1: it's saying that those affected, while it's not going to
- 2:36Speaker 1: impact you know, all of Gregg's customers, that's saying that
- 2:38Speaker 1: those affected, they say, are likely to be those with
- 2:41Speaker 1: higher BERMI, higher frequency customers that are some of Greg's
- 2:45Speaker 1: most valuable customers. So shares falling on the back of
- 2:49Speaker 1: that downgrade from Jeffries.
- 2:51Speaker 4: It comes on top of wider woes for Greg's.
- 2:54Speaker 1: Shares have already been suffering since you know, last September,
- 2:57Speaker 1: particularly sorry September twenty twenty four, and particularly the past
- 3:00Speaker 1: year there's been a lot of questions of about their
- 3:03Speaker 1: kind of over expansion and whether they can sales can
- 3:05Speaker 1: keep up with that expansion. So this is another bit
- 3:09Speaker 1: of bad news weighing on their share price today.
- 3:12Speaker 3: Okay, and in better news, UniCredit share is up over
- 3:15Speaker 3: six percent, yes, ending.
- 3:17Speaker 4: On a high.
- 3:18Speaker 1: So UniCredit is planning to return fifty billion euros over
- 3:20Speaker 1: the next five years, so that's through to twenty thirty.
- 3:23Speaker 1: This is you know, part of their CEO vowing to
- 3:26Speaker 1: improve profitability, improve capital generation. He joined in twenty twenty one.
- 3:30Speaker 1: He's been changing the business a lot. He's cut jobs,
- 3:32Speaker 1: he's exited low pervoiding businesses, he's reallocated resources to more
- 3:37Speaker 1: profitable areas. So profitability return shares have all surged since
- 3:41Speaker 1: he's taken over, and this is the latest news. They're
- 3:44Speaker 1: going to pay out eighty percent of profits in a
- 3:46Speaker 1: mix of cash dividends and share buybacks, and then they're
- 3:49Speaker 1: going to evaluate more returns on a yearly basis, depending
- 3:52Speaker 1: on unicredits excess capital.
- 3:54Speaker 4: This all came.
- 3:55Speaker 1: Alongside fourth quarter results profits b estimate, so hosts of
- 3:58Speaker 1: Good News shares up about five percent money.
- 4:01Speaker 2: The Stockmovers report from Bloomberg Radio. Check back with us
- 4:05Speaker 2: throughout the day for the latest roundup of companies making
- 4:08Speaker 2: news on Wall Street and for the latest market moving headlines.
- 4:12Speaker 2: Listen to Bloomberg Radio Live, catch us on YouTube, Bloomberg
- 4:16Speaker 2: dot com, and on Applecarplay and Android Auto with the
- 4:19Speaker 2: Bloomberg Business App.